Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / TMO - 17 Reasons Why I'm Confident Gilead's Remdesivir Will Work Against COVID-19

TMO - 17 Reasons Why I'm Confident Gilead's Remdesivir Will Work Against COVID-19

Thermo Fisher Scientific Inc

Gilead Sciences (NASDAQ:GILD) declined 3.84% yesterday. I believe that created a major buying opportunity as it's likely based on investors' (yet) limited understanding on Gilead’s strong positioning based on its anti-viral therapy Remdesivir in the battle against COVID-19.

The iShares Nasdaq Biotechnology ETF (IBB) was off by 2.5% and SPDR Biotech ETF (XBI) by 3% yesterday. But it still surprised me Gilead was off that much because there was good news in that Bruce Aylward, senior advisor and international leader of the World Health Organization's China COVID-19 mission,

Read more ...
Stock Information
Company Name: Thermo Fisher Scientific Inc
Stock Symbol: TMO
Market: NYSE
Website: corporate.thermofisher.com
Menu
TMO TMO Quote TMO Short TMO News TMO Articles TMO Message Board
Get TMO Alerts

News, Short Squeeze, Breakout and More Instantly...